These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12215884)

  • 1. [Hawaiian baby woodrose: (Psycho-) Pharmacological effects of the seeds of Argyreia nervosa. A case-orientated demonstration].
    Borsutzky M; Passie T; Paetzold W; Emrich HM; Schneider U
    Nervenarzt; 2002 Sep; 73(9):892-6. PubMed ID: 12215884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable adverse effects in subjects after ingestion of equal doses of Argyreia nervosa seeds.
    Kremer C; Paulke A; Wunder C; Toennes SW
    Forensic Sci Int; 2012 Jan; 214(1-3):e6-8. PubMed ID: 21803515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Argyreia nervosa (Burm. f.): receptor profiling of lysergic acid amide and other potential psychedelic LSD-like compounds by computational and binding assay approaches.
    Paulke A; Kremer C; Wunder C; Achenbach J; Djahanschiri B; Elias A; Schwed JS; Hübner H; Gmeiner P; Proschak E; Toennes SW; Stark H
    J Ethnopharmacol; 2013 Jul; 148(2):492-7. PubMed ID: 23665164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: an ingestion of Hawaiian Baby Woodrose seeds associated with acute psychosis.
    Gertsch JH; Wood C
    Hawaii Med J; 2003 Jun; 62(6):127, 129. PubMed ID: 12886727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two cases of lysergamide intoxication by ingestion of seeds from Hawaiian Baby Woodrose.
    Klinke HB; Müller IB; Steffenrud S; Dahl-Sørensen R
    Forensic Sci Int; 2010 Apr; 197(1-3):e1-5. PubMed ID: 20018470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hawaiian baby rose wood: case report of an argyreia nervosa induced toxic psychosis].
    Göpel C; Maras A; Schmidt MH
    Psychiatr Prax; 2003 May; 30(4):223-4. PubMed ID: 12768530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of legal highs--ergot alkaloid patterns in two Argyreia nervosa products.
    Paulke A; Kremer C; Wunder C; Wurglics M; Schubert-Zsilavecz M; Toennes SW
    Forensic Sci Int; 2014 Sep; 242():62-71. PubMed ID: 25036782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the alkaloid composition of the Hawaiian Baby Woodrose Argyreia nervosa, a common legal high.
    Paulke A; Kremer C; Wunder C; Wurglics M; Schubert-Zsilavecz M; Toennes SW
    Forensic Sci Int; 2015 Apr; 249():281-93. PubMed ID: 25747328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ingestion of Hawaiian Baby Woodrose seeds to obtain a legal high.
    Meyer Karre VM; Heinrich T
    Psychosomatics; 2014; 55(5):517-8. PubMed ID: 25016350
    [No Abstract]   [Full Text] [Related]  

  • 10. Herbal High: Substance-Induced Psychosis after Consumption of Seeds of the Hawaiian Baby Woodrose.
    Sobanski E; Dalm S; Sievers L; Külzer T; Liesenfeld H; Schmidt-Kittler H; Huss M
    Z Kinder Jugendpsychiatr Psychother; 2021 Jul; 49(4):307-311. PubMed ID: 33661700
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of acute hallucinogenic drug toxicity: specific pharmacological intervention.
    Consroe PF
    Bull Natl Clgh Poison Control Cent; 1973; ():1-7. PubMed ID: 4571809
    [No Abstract]   [Full Text] [Related]  

  • 12. Recreational use of D-lysergamide from the seeds of Argyreia nervosa, Ipomoea tricolor, Ipomoea violacea, and Ipomoea purpurea in Poland.
    Juszczak GR; Swiergiel AH
    J Psychoactive Drugs; 2013; 45(1):79-93. PubMed ID: 23662334
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Forrester MB
    J Addict Dis; 2018; 37(3-4):160-164. PubMed ID: 31305228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differences in the pharmacological effect of hallucinogenic and von-hallucinogenic lysergic acid derivatives (LSD 25, deseril, lysenyl, mesenyl)].
    Votava Z; Podvalová I; Vojtĕchovský M
    Arzneimittelforschung; 1966 Feb; 16(2):220-2. PubMed ID: 6014083
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical pharmacology of lysergic acid diethylamide: case reports and review of the treatment of intoxication.
    Blaho K; Merigian K; Winbery S; Geraci SA; Smartt C
    Am J Ther; 1997; 4(5-6):211-21. PubMed ID: 10423613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action.
    Marona-Lewicka D; Nichols DE
    Pharmacol Biochem Behav; 2007 Oct; 87(4):453-61. PubMed ID: 17618679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psychoactive effects of 'legal high': About lysergic acid amide (LSA)].
    Ponté C; Lapeyre-Mestre M
    Therapie; 2017 Oct; 72(5):605-608. PubMed ID: 28457570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Emergent drugs (III): hallucinogenic plants and mushrooms].
    Burillo-Putze G; López Briz E; Climent Díaz B; Munné Mas P; Nogue Xarau S; Pinillos MA; Hoffman RS
    An Sist Sanit Navar; 2013; 36(3):505-18. PubMed ID: 24406363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantum chemical studies on drug actions. 3. Correlation of hallucinogenic and anti-serotonin activity of lysergic acid derivatives with quantum chemical data.
    Kumbar M; Sankar DV
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):65-100. PubMed ID: 4734018
    [No Abstract]   [Full Text] [Related]  

  • 20. The nature of opioid and LSD receptors: structural activity relationship implications.
    Martin WR
    NIDA Res Monogr; 1978; (22):60-9. PubMed ID: 30913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.